Obinutuzumab in the Management of Idiopathic Membranous Nephropathy
NCT05845762 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2023-05-10
Summary
To observe the efficacy and safety of obinutuzumab in Chinese population with idiopathic membranous nephropathy and guide clinical management.
Conditions
- Idiopathic Membranous Nephropathy
Interventions
- DRUG
-
Obinutuzumab Injection
1000mg intravenous injection
Sponsors & Collaborators
-
Qianfoshan Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-31
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
- FDA Drug
- Yes
More Related Trials
-
Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy
NCT07289763 ·Status: RECRUITING ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
NCT04629248 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy
NCT01508468 ·Status: COMPLETED ·Phase: PHASE3
-
Nefecon and Ambrisentan in IgA Nephropathy
NCT07030894 ·Status: RECRUITING ·Phase: PHASE4
-
Obinutuzumab in Treatment of Fibrillary Glomerulonephritis
NCT06295770 ·Status: RECRUITING ·Phase: PHASE2
-
Multitarget Therapy for Idiopathic Membranous Nephropathy
NCT04424862 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy
NCT07029139 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study
NCT07163611 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)
NCT06781944 ·Status: RECRUITING ·Phase: PHASE3
-
An Outcome Analysis of Primary Membranous Nephropathy
NCT06242327 ·Status: RECRUITING
-
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)
NCT05810961 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
NCT05627557 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy
NCT04154787 ·Status: TERMINATED ·Phase: PHASE2
-
Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranous Nephropathy
NCT03475602 ·Status: TERMINATED
-
Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis
NCT04349683 ·Status: UNKNOWN ·Phase: PHASE4
-
Bortezomib for Treating Glomerular Diseases
NCT05383547 ·Status: UNKNOWN ·Phase: NA
-
Study of FG-4592 in Subjects With Chronic Kidney Disease in China
NCT01599507 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid
NCT01161459 ·Status: COMPLETED ·Phase: NA
-
Optimization of a Decision Formula for Optimal Timing of Immunosuppressive Therapy Initiation in Primary Membranous Nephropathy: A Multicenter Retrospective Cohort Study
NCT06924476 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy
NCT05514015 ·Status: RECRUITING ·Phase: PHASE4
-
Prognostic Model of TAC in the Treatment of MN
NCT05667922 ·Status: UNKNOWN
-
The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.
NCT03466801 ·Status: TERMINATED ·Phase: NA
-
A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
NCT06470191 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
NCT00405340 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
REmission in Membranous Nephropathy International Trial (REMIT)
NCT06120673 ·Status: WITHDRAWN ·Phase: PHASE3